Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT02586233
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 106 participants
- Sponsor
- Registry
-
NCT02586233 -
2015-001824-43
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Czechia, France, Germany, Italy, Slovakia, South Korea, Spain, Taiwan, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02586233. Randomized; double masking; primary purpose treatment. Start 2015-09 (actual); primary completion 2019-08-13 (actual). Results posted on 2020-09-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
- Acronym
- ASSENT
- Condition
- Acute Ischemic Stroke
- Condition
- Thrombotic Disease
- Intervention (Drug)
- DS-1040b
- Intervention (Drug)
- Placebo
- Lead sponsor
- Daiichi Sankyo
Record details
- Record id
cardio:ct-nct02586233- Content hash
4d6d5f65d342645ab2f288418ce2a7759e2d50f25ec6ebb21d0b620502014218